Glucotim LA Eye Drop contains Timolol 0.5% w/v, a non-selective beta-adrenergic receptor blocker indicated for the management of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Timolol acts by reducing aqueous humor production in the ciliary body, thereby lowering intraocular pressure and helping to prevent optic nerve damage and visual field loss associated with glaucoma. This formulation is intended for topical ophthalmic use and provides a sustained effect suitable for once or twice daily administration as prescribed. Patients should be advised to avoid contact with the tip of the dropper to prevent contamination and to remove contact lenses prior to instillation, waiting at least 15 minutes before reinsertion. Common adverse reactions may include ocular irritation, burning, stinging, dry eyes, and blurred vision. Systemic absorption can occur and may result in cardiovascular or respiratory effects such as bradycardia, hypotension, or bronchospasm, particularly in susceptible individuals with asthma or chronic obstructive pulmonary disease. Glucotim LA Eye Drop should be used with caution in patients with cardiac or pulmonary conditions and is contraindicated in those with hypersensitivity to Timolol or other beta-blockers. Regular monitoring of intraocular pressure and patient response is recommended to ensure therapeutic efficacy and safety.